Older women suffering from clinical frailty stand to benefit from the first potential medical treatment for the condition a hormone that stimulates appetite, was administered to older women diagnosed with frailty, a common geriatric syndrome characterized by unintentional weight loss, weakness, exhaustion and low levels of anabolic hormones which increases risk of falls, hospitalizations, disability, and death. Those who received ghrelin infusions consumed 51 percent more calories. (source: uphs.upenn.edu)
|